Understand the source comparison
Research vs Clinical LIPO-C — The Compliance Pathway Difference
Research-grade LIPO-C purchased for laboratory studies operates under 21 CFR 312.2(b)(1), the investigational use exemption. This regulation permits manufacture and interstate shipment of unapproved drug substances when intended solely for preclinical research
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Research-grade LIPO-C purchased for laboratory studies operates under 21 CFR 312.2(b)(1), the investigational use exemption. This regulation permits manufacture and interstate shipment of unapproved drug substances when intended solely for preclinical research, provided the substance is not promoted for clinical use and the buyer is a bona fide research entity. Suppliers meeting this standard. Real Peptides maintains FDA registration as a research peptide manufacturer and requires institutional purchase verification. Face no legal barriers in 2026. The peptide is synthesised to research-grade purity specifications (typically ≥98% by HPLC), shipped with a certificate of analysis, and labelled 'not for human consumption'.
- Clinical LIPO-C follows an entirely different pathway. When a physician prescribes LIPO-C for a specific patient based on individualised clinical assessment, the compounding pharmacy preparing that dose operates under Section 503A (patient-specific compounding) or 503B (outsourcing facility) of the Federal Food, Drug, and Cosmetic Act. This requires: (1) a valid prescription from a licensed prescriber with prescribing authority in the patient's state, (2) preparation in a state-licensed pharmacy meeting USP Chapter 797 sterile compounding standards, (3) adherence to state medical board telemedicine statutes if prescribed remotely, and (4) no promotional marketing of the compounded product as a standardised drug.
- The legal risk concentrates at the vendor level when these pathways blur. A company selling LIPO-C vials to individuals without prescriptions while simultaneously publishing blog content about 'clinical benefits' and 'dosing protocols'. That's where state pharmacy boards and FDA Warning Letters target enforcement. Real Peptides avoids this trap entirely by restricting sales to verified research accounts and maintaining clear research-use-only labelling across all product pages and documentation.